During this two-day oncology congress, experts will reflect on groundbreaking and practice-changing studies from the past year, followed by a clear overview of tomorrow's standard of care.

The program covers new developments in the treatment of breast, colorectal, head and neck, urothelial, and gynecological cancers, including immunotherapy combinations and novel neoadjuvant treatment strategies.

Expect sharp insights, recent results, and findings you can apply in your clinical practice.